Stem Cell Therapy in Multiple Myeloma

Roshna P P
Roshna P P
Sreejith K
Sreejith K
Government Medical College

Send Message

To: Author

Stem Cell Therapy in Multiple Myeloma

Article Fingerprint

ReserarchID

PS10H

Stem Cell Therapy in Multiple Myeloma Banner

AI TAKEAWAY

Connecting with the Eternal Ground
  • English
  • Afrikaans
  • Albanian
  • Amharic
  • Arabic
  • Armenian
  • Azerbaijani
  • Basque
  • Belarusian
  • Bengali
  • Bosnian
  • Bulgarian
  • Catalan
  • Cebuano
  • Chichewa
  • Chinese (Simplified)
  • Chinese (Traditional)
  • Corsican
  • Croatian
  • Czech
  • Danish
  • Dutch
  • Esperanto
  • Estonian
  • Filipino
  • Finnish
  • French
  • Frisian
  • Galician
  • Georgian
  • German
  • Greek
  • Gujarati
  • Haitian Creole
  • Hausa
  • Hawaiian
  • Hebrew
  • Hindi
  • Hmong
  • Hungarian
  • Icelandic
  • Igbo
  • Indonesian
  • Irish
  • Italian
  • Japanese
  • Javanese
  • Kannada
  • Kazakh
  • Khmer
  • Korean
  • Kurdish (Kurmanji)
  • Kyrgyz
  • Lao
  • Latin
  • Latvian
  • Lithuanian
  • Luxembourgish
  • Macedonian
  • Malagasy
  • Malay
  • Malayalam
  • Maltese
  • Maori
  • Marathi
  • Mongolian
  • Myanmar (Burmese)
  • Nepali
  • Norwegian
  • Pashto
  • Persian
  • Polish
  • Portuguese
  • Punjabi
  • Romanian
  • Russian
  • Samoan
  • Scots Gaelic
  • Serbian
  • Sesotho
  • Shona
  • Sindhi
  • Sinhala
  • Slovak
  • Slovenian
  • Somali
  • Spanish
  • Sundanese
  • Swahili
  • Swedish
  • Tajik
  • Tamil
  • Telugu
  • Thai
  • Turkish
  • Ukrainian
  • Urdu
  • Uzbek
  • Vietnamese
  • Welsh
  • Xhosa
  • Yiddish
  • Yoruba
  • Zulu
Font Type
Font Size
Font Size
Bedground

Abstract

Multiple myeloma is a haematogical malignancy caused by abnormality of plasma cells characterized by (a) hypercalcemia, (b) renal insufficiency or failure, (c)bone pain and abnormal bone radiographs, (d) anemia and (e) a monoclonal protein in urine or serum or both. It begins in the form known as monoclonal gammopathy of undetermined significance (MGUS) and progresses to asymptomatic myeloma and then lastly to symptomatic myeloma. The three main domains in the understanding of Pathophysiology are cytokines and cell signaling, bone Marrow Microenvironment and cell Cycle. Bifunctional alkylating agents like Melphalan and cyclophosphamide are considered as standard therapy for multiple myeloma. Patients who are chosen for stem cell transplantation can be treated with Lenalidomide, an immunomodulatory agent and an aminosustituted variant of Thalidomide. It is given along with dexamethas one. In stem cell therapy, the patients receive stem cells intravenously similar to the blood transfusion and this phase takes 1-5 hours. After entering the blood stream through a process called engraftment, the stem cell produce new WBCs, RBCs and platelets. The immune rejection of donor cells by the host immune system is a major drawback of transplantation. Stem cell therapy in multiple myeloma is very effective and should be opted as one among the best for both older patients and patients younger than 65 years.

References

19 Cites in Article
  1. M Sundarjagannath (2008). Pathophysiogical Under spinnings of Multiple Myeloma progression.
  2. Evangelos Terpos (2018). Pathogenesis of bone disease in multiple myeloma: from bench to bedside.
  3. Lynda Campbell (1999). Conventional Cytogenetics in Myeloma.
  4. Robert Kyle (2009). Treatment of Multiple Myeloma: A comprehensive Review.
  5. Christian Gerecke (2016). The Diagnosis and treatment of multiple myeloma.
  6. Leonard Naymagon,Maher Abdul-Hay (2016). Novel agents in the treatment of multiple myeloma: a review about the future.
  7. Ajay Gupta,Lalit Kumar (2011). Evolving role of high dose stem cell therapy in multiple myeloma.
  8. Laurent Garderet (2016). Upfront autologous stem cell transplantation for newly diagnosed elderly multiple myeloma patients: a prospective multicenter study.
  9. Yin (2018). Allogenic stem cell transplantation for multiple myeloma: a systematic review and meta-analysis frok 2007 to 2017.
  10. Reddy Stem cell therapy for cancer.
  11. R Zeiser,H Bertz,A Spyridonidis,L Houet,J Finke (2004). Donor lymphocyte infusions for multiple myeloma: clinical results and novel perspectives.
  12. T Jeevani Stem cell transplantation-Types. Risks and Benefits.
  13. Shaji Kumar (2009). Stem cell transplantation for multiple myeloma.
  14. William Matsui,Ivan Borrello,Constantine Mitsiades (2012). Autologous Stem Cell Transplantation and Multiple Myeloma Cancer Stem Cells.
  15. G Shernan,Holtan (2006). Timing of autologous stem cell transplantation from last chemotherapy affects lymphocyte collection and survival in non-Hodkin lymphoma.
  16. A Morie,Gertz (2014). How we manage autologous stem cell transplantation for patients with multiple myeloma.
  17. W Mark,Owdell (1997). Less is more": The Role of Purging in Hematopoietic Stem Cell Transplantation.
  18. Anne Lennard (2001). Stem cell transplantation.
  19. (2012). The benefits and risks of stem cell technology.

Funding

No external funding was declared for this work.

Conflict of Interest

The authors declare no conflict of interest.

Ethical Approval

No ethics committee approval was required for this article type.

Data Availability

Not applicable for this article.

How to Cite This Article

Roshna P P. 2018. \u201cStem Cell Therapy in Multiple Myeloma\u201d. Global Journal of Medical Research - C: Microbiology & Pathology GJMR-C Volume 18 (GJMR Volume 18 Issue C1).

Download Citation

Journal Specifications

Crossref Journal DOI 10.17406/gjmra

Print ISSN 0975-5888

e-ISSN 2249-4618

Keywords
Classification
GJMR-C Classification NLMC Code: WH 540
Version of record

v1.2

Issue date
July 30, 2018

Language
en
Experiance in AR

Explore published articles in an immersive Augmented Reality environment. Our platform converts research papers into interactive 3D books, allowing readers to view and interact with content using AR and VR compatible devices.

Read in 3D

Your published article is automatically converted into a realistic 3D book. Flip through pages and read research papers in a more engaging and interactive format.

Article Matrices
Total Views: 3130
Total Downloads: 1478
2026 Trends
Related Research
Our website is actively being updated, and changes may occur frequently. Please clear your browser cache if needed. For feedback or error reporting, please email [email protected]

Request Access

Please fill out the form below to request access to this research paper. Your request will be reviewed by the editorial or author team.
X

Quote and Order Details

Contact Person

Invoice Address

Notes or Comments

This is the heading

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

High-quality academic research articles on global topics and journals.

Stem Cell Therapy in Multiple Myeloma

Roshna P P
Roshna P P <p>Government Medical College</p>
Sreejith K
Sreejith K

Research Journals